# Role of the Microbiome in Graves' Orbitopathy

> **NCT02373995** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 60 (estimated)

## Conditions studied

- Graves' Disease

## Interventions

- **BIOLOGICAL:** LAB4

## Key facts

- **NCT ID:** NCT02373995
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02
- **Primary completion:** 2015-07
- **Final completion:** 2016-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2015-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02373995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02373995, "Role of the Microbiome in Graves' Orbitopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02373995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*